ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 150 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $114,211 | +33.7% | 5,574 | +29.6% | 0.01% | +66.7% |
Q2 2023 | $85,441 | +16.0% | 4,300 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $73,659 | -16.2% | 4,300 | 0.0% | 0.00% | -25.0% |
Q4 2022 | $87,935 | +83.2% | 4,300 | +42.9% | 0.00% | +100.0% |
Q3 2022 | $48,000 | +17.1% | 3,009 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $41,000 | -14.6% | 3,009 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $48,000 | -27.3% | 3,009 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $66,000 | -26.7% | 3,009 | 0.0% | 0.00% | -33.3% |
Q3 2021 | $90,000 | -32.3% | 3,009 | 0.0% | 0.00% | -40.0% |
Q2 2021 | $133,000 | -0.7% | 3,009 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $134,000 | -18.8% | 3,009 | 0.0% | 0.01% | -37.5% |
Q4 2020 | $165,000 | +139.1% | 3,009 | 0.0% | 0.01% | +166.7% |
Q3 2020 | $69,000 | +9.5% | 3,009 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $63,000 | +75.0% | 3,009 | +18.0% | 0.00% | +50.0% |
Q1 2020 | $36,000 | -37.9% | 2,549 | 0.0% | 0.00% | -33.3% |
Q4 2019 | $58,000 | +93.3% | 2,549 | 0.0% | 0.00% | +200.0% |
Q3 2019 | $30,000 | -21.1% | 2,549 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $38,000 | +15.2% | 2,549 | +36.3% | 0.00% | 0.0% |
Q1 2019 | $33,000 | +17.9% | 1,870 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $28,000 | -39.1% | 1,870 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $46,000 | +24.3% | 1,870 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $37,000 | – | 1,870 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |